In the Real World Study, the Efficacy and Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular Disease
Not yet recruitingOBSERVATIONAL
Enrollment
50
Participants
Timeline
Start Date
April 30, 2023
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2028
Conditions
Cerebral InfarctionStrokeNervous System DiseasesIschemic Cerebrovascular Disease
All Listed Sponsors
lead
Qianfoshan Hospital
OTHER
NCT05716646 - In the Real World Study, the Efficacy and Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular Disease | Biotech Hunter | Biotech Hunter